Beijing Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BEIJING, and what generic and branded alternatives to BEIJING drugs are available?
BEIJING has six approved drugs.
There is one tentative approval on BEIJING drugs.
Drugs and US Patents for Beijing
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beijing | NIACIN | niacin | TABLET, EXTENDED RELEASE;ORAL | 214428-001 | Nov 22, 2021 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Beijing Tide Pharm | COLESEVELAM HYDROCHLORIDE | colesevelam hydrochloride | TABLET;ORAL | 206036-001 | Oct 14, 2021 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Beijing | FOSCARNET SODIUM | foscarnet sodium | INJECTABLE;INJECTION | 213987-001 | Nov 29, 2023 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Beijing Yiling | LETROZOLE | letrozole | TABLET;ORAL | 205869-001 | Nov 14, 2018 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.